ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 039,33
-1,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Mirum Pharmaceuticals Inc (MIRM)

  7. Mirum Pharmaceuticals Inc (MIRM) Actualités

MIRM Mirum Pharmaceuticals Inc

25,84
0,24 (0,94%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mirum Pharmaceuticals Inc MIRM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,24 0,94% 25,84 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
26,01 25,66 26,24 25,84 25,60
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:10BWMirum Pharmaceuticals to Announce First Quarter 2024..
11/4/202403:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
02/4/202414:30BWMirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution)..
25/3/202412:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
13/3/202423:00BWMirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for..
09/3/202401:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
05/3/202414:00BWMirum Pharmaceuticals to Participate in Upcoming Investor..
29/2/202414:30BWHepatology Publishes Six-Year Data Demonstrating Improved..
28/2/202423:01EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28/2/202422:05EDGAR2Form 8-K - Current report
28/2/202422:03BWMirum Pharmaceuticals Reports Fourth Quarter and Year-End..
21/2/202422:05BWMirum Pharmaceuticals to Announce Fourth Quarter and..
10/2/202403:15BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
06/2/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
16/1/202422:15EDGAR2Form 8-K - Current report
16/1/202414:30BWMirum Pharmaceuticals Appoints Joanne Quan, MD as Chief..
11/1/202401:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
10/1/202402:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:30EDGAR2Form 8-K - Current report
08/1/202414:30BWMirum Pharmaceuticals Announces Preliminary Unaudited 2023..
03/1/202414:45BWMirum Pharmaceuticals to Present at the 42nd Annual J.P...
18/12/202322:06EDGAR2Form 8-K - Current report
18/12/202314:30BWMirum Pharmaceuticals Announces Data from EMBARK Phase 2b..
09/12/202301:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
06/12/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:00BWLIVMARLI (maralixibat) di Mirum Pharmaceutical è stato..
20/11/202322:05BWMirum Pharmaceuticals to Present at the 2023 Evercore ISI..
16/11/202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:00BWMirum Pharmaceuticals Presents New Data at The Liver..
10/11/202323:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
03/11/202313:30BWMirum Pharmaceuticals to Present at the 2023 UBS Biopharma..
02/11/202322:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/11/202321:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:06EDGAR2Form 8-K - Current report
02/11/202321:05EDGAR2Form 8-K/A - Current report: [Amend]
02/11/202321:05BWMirum Pharmaceuticals Reports Third Quarter 2023 Financial..
30/10/202313:30BWMirum Pharmaceuticals to Present New Data at The Liver..
27/10/202314:45BWMirum Pharmaceuticals to Announce Third Quarter 2023..
17/10/202322:39EDGAR2Form 8-K - Current report
17/10/202322:30BWMirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI..

Dernières Valeurs Consultées

NASDAQ
MIRM
Mirum Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés